Aptar

Crystal Lake, Illinois, July 30, 2026 -- AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today reported the following second quarter results for the period ended June 30, 2026, as compared to the corresponding period of the last fiscal year.

Aptar today announced that it has been named one of the World’s Most Sustainable Companies 2026 by TIME for the third consecutive year. Aptar is ranked 261 out of 750 global companies evaluated by TIME and its partner Statista. “We are honored to be named one of TIME’s World’s Most Sustainable Companies for the third consecutive year,” said Stephan B. Tanda, Aptar President and CEO.

Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, today announced that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a Certificate of Good Manufacturing Practice (GMP) Compliance following its inspection of Aptar Pharma’s Nanopharm facility in Wales.

Aptar Closures now offers Harmonic, a liner-less flip-top sport cap for hot-fill beverage applications. The closure helps beverage brands improve the consumer experience while reinforcing product security in a modern, customizable design. As beverage consumption continues to shift toward on-the-go occasions, sport closures have become an important way for brands to differentiate and create value.

Aptar, a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, announces the first commercial launch of its innovative auto-loading, dosing dropper technology called NeoDropper Autoload. Aptar Beauty’s technology is featured on Dermalogica’s FutureCode Booster skincare product.

Noble, an Aptar Pharma company, recently welcomed community leaders, employees, and representatives from Redemption Home to its Orlando headquarters for a special presentation ceremony recognizing its support for the organization's mission of providing mentorship, stability, and opportunity for young men across Central Florida.

Crystal Lake, Illinois, July 17, 2026 - Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, today announced a collaborative system-level framework for injectable drug delivery systems. Building on more than a decade of supporting pharmaceutical customers in respiratory and ophthalmic drug development, Aptar Pharma will work with partners to develop data packages that combine integrated system-level testing and performance data for injectable therapies.

Crystal Lake, Illinois, July 16, 2026 -- AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that the Board declared a quarterly cash dividend of $0.48 per share. The payment date is August 20, 2026, to stockholders of record as of July 30, 2026.

Aptar Pharma has developed dermal drug delivery systems with the patient or consumer in mind. By truly understanding the impact of our products on the user, we are able to define the performance parameters and usability standards for dermal drug delivery products and deliver an advanced patient- and user experience.

Aptar today announced that it has been named one of the America’s Best Companies 2026 by TIME. Aptar is ranked 83 out of 1000 companies evaluated by TIME and its partner Statista. Aptar is ranked within the top five companies in the Engineering, Manufacturing and Medical Technology category and is ranked in the top 10 companies nationwide for sustainability transparency.